0001209191-20-052267.txt : 20200928 0001209191-20-052267.hdr.sgml : 20200928 20200928193702 ACCESSION NUMBER: 0001209191-20-052267 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200924 FILED AS OF DATE: 20200928 DATE AS OF CHANGE: 20200928 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sandor Victor CENTRAL INDEX KEY: 0001620368 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39527 FILM NUMBER: 201205695 MAIL ADDRESS: STREET 1: C/O ARRAY BIOPHARMA INC. STREET 2: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Prelude Therapeutics Inc CENTRAL INDEX KEY: 0001678660 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811384762 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 200 POWDER MILL ROAD CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: (302) 547-3768 MAIL ADDRESS: STREET 1: 200 POWDER MILL ROAD CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: Prelude Therapeutics Inc. DATE OF NAME CHANGE: 20160630 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-09-24 0 0001678660 Prelude Therapeutics Inc PRLD 0001620368 Sandor Victor C/O PRELUDE THERAPEUTICS INCORPORATED 200 POWDER MILL ROAD WILMINGTON DE 19801 1 0 0 0 Director Stock Option (right to buy) 19.00 2020-09-24 4 A 0 3458 0.00 A 2030-09-23 Common Stock 3458 3458 D The stock option vests as of 1/36 of the total shares monthly beginning on September 24, 2020 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. /s/ Brian Piper, as Attorney-in-Fact for Victor Sandor 2020-09-28